Structure determination. For structural analyses, we evaluated multiple TRPV4 orthologs and identified the X. tropicalis channel, which shares 78% sequence identity with the human protein, as a promising candidate. We modified the full-length channel by
T RP ion channels are central to a vast array of physiological functions, responding to a wide spectrum of physical and chemical stimuli [1] [2] [3] [4] [5] . Based on amino acid sequence similarity, mammalian TRP channels are grouped into six subfamilies: TRPA, TRPC, TRPM, TRPML, TRPP and TRPV 2 . TRPV subfamily member 4 (TRPV4), a Ca 2+ -permeable nonselective cation channel, is expressed in multiple tissues and has been implicated in many biological processes, including osmoregulation [6] [7] [8] [9] [10] , bone homeostasis 11 , control of vascular tone 12 , regulation of adipose thermogenesis and inflammation 13 , and nociception 14, 15 . The biological versatility of TRPV4 is enabled by polymodal gating behavior: the channel is activated by stimuli ranging from cell swelling [8] [9] [10] , shear stress 16, 17 and moderate heat 18, 19 to chemical agonists 20, 21 . Over fifty TRPV4 mutations have been linked to a variety of inherited diseases, including osteoarthropathy, skeletal dysplasias and neurological disorders, such as congenital distal spinal muscular atrophy and Charcot-Marie-Tooth disease type 2C 22, 23 . Therefore, TRPV4 presents as a prominent potential drug target for the treatment of a broad range of diseases.
Recently, structures of the TRPV subfamily members, including TRPV1 (refs [24] [25] [26] ), TRPV2 (refs 27, 28 ) and TRPV6 (refs 29, 30 ), determined at near-atomic resolution by single-particle cryo-EM or X-ray crystallography have revealed the overall architecture of these tetrameric channels. Each subunit consists of a transmembrane region resembling that of other tetrameric voltage-gated ion channels (VGIC) and a cytosolic portion characteristic of TRPV channels. Moreover, structures of TRPV1 in multiple functional states have illuminated two constrictions along the ion permeation pathway, an upper gate at the selectivity filter and a lower gate at the inner helix bundle-crossing region, as well as conformational changes at these two gates upon channel activation 24, 25 . Interestingly, although the architecture of all TRPV channels may be similar, intriguing variations have been noted. In the TRPV1 and TRPV2 structures, like in many VGIC structures, the S1-S4 domain (termed the voltage-sensor domain in VGICs) packs against the pore domain S5-S6 from an adjacent subunit of the tetramer (domain swapped) rather than from the same subunit (non-swapped). In contrast, in structures of TRPV6 and its variants, both domain-swapped and non-swapped transmembrane arrangements have been observed 29, 30 . Recent studies have also revealed non-swapped transmembrane architecture in multiple VGICs including Eag1 (ref. 31 ), Slo1 (ref. 32 ) and HCN 33 . These differences and variations underscore structural divergence between closely related tetrameric cation channels and potentially distinct gating mechanisms.
Functionally, TRPV4 has been one of the most intensively studied TRP channels owing to its essential physiological and pathological roles 22, 23 . However, structural information has been limited to crystallographic studies of isolated cytoplasmic domains 34, 35 and a cryo-EM model at very low (35 Å) resolution 36 . To better understand the structural basis underlying its unique properties, we set out to determine high-resolution structures of TRPV4. Here we present the cryo-EM structure of TRPV4 determined at 3.8-Å resolution and X-ray crystallographic analyses of the ion-binding sites in the pore. These combined structural approaches illuminate previously unattainable features that are unique to TRPV4 and provide a molecular map for disease mutations. More broadly, we show how single-particle cryo-EM structure determination at near-atomic resolution, together with anomalous X-ray diffraction even at limited resolution, illustrates a powerful duo for the investigation of ion channel structure and function.
*
The transient receptor potential (TRP) channel TRPV4 participates in multiple biological processes, and numerous TRPV4 mutations underlie several distinct and devastating diseases. Here we present the cryo-EM structure of Xenopus tropicalis TRPV4 at 3.8-Å resolution. The ion-conduction pore contains an intracellular gate formed by the inner helices, but lacks any extracellular gate in the selectivity filter, as observed in other TRPV channels. Anomalous X-ray diffraction analyses identify a single ion-binding site in the selectivity filter, thus explaining TRPV4 nonselectivity. Structural comparisons with other TRP channels and distantly related voltage-gated cation channels reveal an unprecedented, unique packing interface between the voltage-sensor-like domain and the pore domain, suggesting distinct gating mechanisms. Moreover, our structure begins to provide mechanistic insights to the large set of pathogenic mutations, offering potential opportunities for drug development.
deleting the unstructured N-and C-terminal regions and generated a truncated construct consisting of residues 133-797, which yielded crystals (Fig. 1a) . This construct contains essentially all functional domains, including the proline-rich domain (PRD), the ankyrinrepeat domain (ARD), the linker domain, the transmembrane domain and the TRP domain. To improve X-ray diffraction, we further eliminated a glycosylation site by introducing the point mutation N647Q. The resulting construct TRPV4 cryst (133-797 N647Q) permitted crystallographic analyses of ion binding and cryo-EM structure determination at near-atomic resolution.
Like the full-length wild-type channel, TRPV4 cryst generates active channels when expressed in mammalian cells. The channels are robustly activated by the specific TRPV4 agonist GSK1016790A (GSK101) in intact cells, as detected using radiolabeled rubidium ( 86 Rb + ) efflux (Fig. 1b and Supplementary Fig. 1 ), and in excised patches (Fig. 1c,d and Supplementary Fig. 2 ). TRPV4 cryst has single-channel conductance (272 ± 13 pS in symmetrical 150 mM KCl at -100 mV membrane voltage) essentially identical to that of the full-length channel (280 ± 11 pS in symmetrical 150 mM KCl) and maintains ion permeation and blockage properties (Fig. 1c,d and Supplementary Fig. 2 ). We observed less activity of TRPV4 cryst constructs in CosM6 cells, both in 86 
Rb
+ efflux experiments and in patch-clamp recordings, which appears to arise from impeded trafficking of expressed TRPV4 cryst to the plasma membrane (PM) (Supplementary Fig. 2a) . Consistently, previous studies have shown that the C-terminal tail region, which is absent in TRPV4 cryst , is essential for channel localization to the PM 37, 38 . Together, these results indicate that TRPV4 cryst retains similar pharmacological activation and inhibition and biophysical pore properties to wild-type TRPV4, but does not traffic efficiently to the cell membrane.
The cryo-EM structure of TRPV4 cryst was determined at an overall resolution of 3.8 Å with C4 symmetry imposed (Table 1 and Supplementary Fig. 3 ). Local resolution estimates indicate that the transmembrane, TRP, and linker domains were better resolved than the ARD. The crystal structure of the ARD (PDB 4DX2) was docked into the density map and adjusted 34 , and the rest of the channel was built de novo using bulky side chains to register the amino acid sequence. Refinement of the atomic coordinates was performed in real and reciprocal space against one of the independently calculated half-maps (working) and validated against the other half-map (free) and the full map ( Supplementary Fig. 4 ). The refined model has good geometry and fits well into the electron density map ( Supplementary Fig. 4 ).
Overall architecture. The symmetric tetramer architecture of TRPV4 is similar to those of other TRPV channels, including TRPV1, TRPV2 and TRPV6 (Fig. 2a,b) . The transmembrane domain resembles that of VGICs, comprising six membrane-spanning segments S1 to S6. The first four helices constitute a structural unit, the S1-S4 domain, analogous to the voltage-sensor domain in VGICs. Four S1-S4 domains surround the central ion-conduction pore formed by S5 and S6 and the intervening pore loops from four identical subunits. Similarly to TRPV1, TRPV2 and many VGICs, TRPV4 adopts a domain-swapped arrangement between the S1-S4 domain and the pore domain S5-S6. In contrast to TRPV1 and TRPV2, the connector between these two domains, the S4-S5 linker, adopts an ordered loop structure rather than an α -helix (Fig. 2c) . In VGICs, the S4-S5 linker usually forms an α -helical segment functioning as a mechanical lever to couple voltage-sensor activation and pore opening [39] [40] [41] , and the absence of this α -helical coupler results in different gating behavior 31, 33 . In addition, the relative position of the S1-S4 domain to the pore domain in TRPV4 is distinct from that of TRPV1 and TRPV2. As we will discuss, the packing interface between the S1-S4 and pore domains in TRPV4 is unique among TRP channels and distantly related VGICs.
Like other TRPV channels, the intracellular domains of each subunit of the tetrameric TRPV4 channel contain an N-terminal ARD followed by a linker domain that precedes the S1-S4 domain (Fig. 2c) . In the linker domain, two β -strands, β 1 and β 2, in conjunction with a C-terminal β -strand, β 3, constitute a three-stranded β -sheet, which not only tethers the N-terminal ARD to the C terminus within each subunit, but also interacts with the ARD from an adjacent subunit. These long-range tethering and packing interactions create an important subunit-subunit assembly interface 24, 27 . Following the β -strands, a helix-turn-helix (HTH) motif and a pre-S1 helix snugly accommodate the C-terminal TRP helix ( Supplementary  Fig. 5 ), a conserved sequence motif among TRP channels that follows the inner helix S6 and regulates channel activity 42 . The amphipathic TRP helix runs parallel to the membrane and is in close contact with the ordered S4-S5 linker, which connects the S1-S4 and pore domains. Such arrangements strategically place the TRP helix between the cytosolic and transmembrane domains, where distinct physical or chemical stimuli exert their forces. The TRP helix is thus well positioned to orchestrate conformational changes between these two regions to influence the gate.
Ion permeation pathway. We calculated the pore radius along the ion permeation pathway using the program HOLE 43 and observed a single constriction: the lower gate, where inner helices cross at the intracellular side. Side chains of M714 define the narrowest point, measuring 5.3 Å in diameter, which is sufficient to prevent ion passage (Fig. 3a,b) , thus indicating that the structure represents a closed conformation of the channel. This lower gate is a conserved structural feature among TRPV channels, and the dimension of the TRPV4 gate is comparable to those of the closed lower gates in other TRPV channels ( Fig. 3c-e) . The corresponding methionine residues in TRPV2 (M643) 27 and TRPV6 (M577) 29 constitute the lower gates, whereas in TRPV1, side chains of the equivalent methionine (M682) point away from the central pathway, and instead, the nearby I679 defines the lower gate 24, 25 . Interestingly, despite the high amino acid sequence conservation of S6 helices among TRPV channels, the lower gates are constructed by different residues (Fig. 3b-e and Supplementary Fig. 5 ).
In addition to the lower intracellular gate in S6, other TRPV channels have a second constriction in the selectivity filter, the so-called upper gate, close to the extracellular side. Structures of TRPV1 in closed and open states have indicated that both the upper and lower gates undergo conformational changes upon channel activation, suggesting a dual gating mechanism 24, 25 . Indeed, the selectivity-filter gate in TRPV1 responds to activation by heat and chemical ligands [44] [45] [46] . In both TRPV1 and TRPV2, side chains of methionine residues form a narrow, hydrophobic constriction, and the carbonyl oxygen atoms of glycine residues define the narrowest point in the selectivity filter (4.8 Å in TRPV1 and 5.2 Å in TRPV2) (Fig. 3c,d ). The selectivity-filter sequences (TIGMGD/E) are well conserved among TRPV1, TRPV2 and TRPV4 channels ( Supplementary Fig. 5 ). However, the selectivity filter is exceptionally wide in TRPV4 ( Fig. 3b-e ). In our TRPV4 structure, the narrowest point in this region, defined by the carbonyl oxygen atoms of the corresponding glycine residues G675, is 10.6 Å in diameter. This distance is larger than the equivalent distance in the open, activated TRPV1 structure (7.6 Å) and is large enough to conduct even hydrated cations such as Na + , K + , and Ca 2+ , which have effective diameters in the range of 6-10 Å. Interestingly, the cryo-EM structure of a full-length TRPV2 channel 28 , albeit at low resolution, showed wider openings at both the upper and lower gates compared with a truncated construct 27 , suggesting a potential dualgating mechanism for TRPV2. In marked contrast, the wide-open selectivity filter of TRPV4 in a closed state suggests the absence of any upper gate. Consistent with this notion, no physiological stimuli have been identified that work through the selectivity filter of TRPV4 to activate the channel.
Ion binding in the pore. TRPV4 cryst crystals grew in the absence of agonists or antagonists and belonged to space group P42 1 2, with each asymmetric unit containing a single subunit of the tetrameric channel. Despite extensive optimization, native crystals diffracted X-rays to a limited resolution of ~5 Å, which precluded atomic structure determination by X-ray crystallography. However, using a single subunit from the cryo-EM structure as the search model, we obtained molecular replacement solutions for our collected X-ray diffraction datasets. The tetrameric channel structure generated by a crystallographic four-fold symmetry is essentially the same as the cryo-EM structure, strengthening our interpretation of the cryo-EM reconstruction. Moreover, anomalous X-ray diffraction allows unambiguous determination of the locations of certain atoms in crystal structures, owing to the characteristic anomalous dispersion near their X-ray absorption edges. Analogous methods in single-particle cryo-EM currently do not exist. Therefore we used X-ray crystallography to identify ion-binding sites along the permeation pathway.
TRPV4 is a nonselective cation channel with higher permeability for divalent ions, such as Ca Fig. 2 ), respectively, because these ions have strong signals in anomalous X-ray diffraction. We also examined gadolinium ions (Gd 3+ ), which provide strong anomalous X-ray diffraction signals and block many TRP channels, including TRPV4 ( Supplementary Fig. 2 ). We cocrystallized TRPV4 cryst with Cs + and Ba 2+ and soaked apo crystals with Gd 3+ and then measured X-ray diffraction at wavelengths close to the respective absorption edges to determine ion-binding sites in the crystals (Table 2 ). Even at limited resolutions, the anomalous difference maps for Cs + , Ba 2+ and Gd 3+ clearly showed a single peak representing the cation-binding site, located on the central pore axis in the vicinity of the carbonyl oxygen atoms of G675 (Fig. 4a-d) .
The distance between diagonal oxygen atoms is ~10.6 Å, as in the cryo-EM structure, and appears to be large enough to accommodate hydrated ions at this site. The locations are only slightly different for these ions with various charges and permeation and blockage properties. No additional anomalous difference electron densities are observed in the outer vestibule region. Thus, in our TRPV4 structures, the wide-open selectivity filter coordinates a single hydrated cation at nearly the same location, regardless of ion valency. This clearly explains the nonselectivity of the channel. For a filter with a single ion-binding site, any entering ion, be it Ca 2+ , K + or Na + , can spontaneously exit to either side of the ion-binding site. In other words, it can permeate. However, for a filter with multi-ion-binding sites, an entering ion with lower affinity would be stopped by a previously bound ion with higher affinity along the permeation path and, therefore, would exit to the same side it entered. That is, it cannot permeate. Multi-ion occupancy appears essential for selectivity, as elegantly demonstrated in the NaK channel and its variants [48] [49] [50] [51] . The exception we observed for Gd 3+ , which blocked the channel at millimolar concentration ( Supplementary Fig. 2e ), is probably explained by its abnormally high affinity for the filter owing to its carried charge.
In our cryo-EM reconstruction, we noticed additional robust densities in the selectivity-filter region that could not be attributed to polypeptide (Fig. 4e,f) . X-ray diffraction analyses eliminate the possibility of bound ions accounting for these densities. Therefore, we attribute these large densities to additional tightly bound molecules that copurify with the channel protein. We suggest that these additional molecules are likely to be lipids, consistent with our observation that additionally supplemented lipids are necessary to maintain protein stability and prevent aggregation during purification. Intriguingly the additional densities are intercalated between the selectivity-filter loops and appear to be an integral part of the selectivity filter, filling the otherwise empty space created by the wide-open selectivity filter (Fig. 4e,f) . Although lipids are well-recognized modulators of ion channel activity and direct interaction of lipids and the ion-conduction pore may not be uncommon [52] [53] [54] , putative lipid binding in the pore represents an unprecedented feature in TRPV4, which, to our knowledge, has not been noted in other tetrameric cation channels. The identity and functional role of these copurified molecules must await further characterization.
Unique arrangement of the S1-S4 domain. In TRP channels and in VGICs, the peripheral S1-S4 domains and the central pore domains S5-S6 can be arranged in a domain-swapped or non-swapped manner, leading to distinct activation mechanisms 31, 33 . Among available TRPV channel structures, TRPV1 and TRPV2 are domain swapped 24, 27 , whereas TRPV6 can be domain swapped or nonswapped 29, 30 . Nonetheless, the overall location and orientation of the S1-S4 and S5-S6 domains are similar, and these domains align well among TRPV1, TRPV2 and TRPV6 channels. Like TRPV1 and TRPV2, TRPV4 adopts a domain-swapped configuration but shows striking differences in the packing of S1-S4 against the S5-S6 transmembrane domains (Fig. 5a-c ).
An objective comparison of structural differences between TRPV4 and other TRPV channels, including TRPV1, TRPV2 and TRPV6, is achieved by superimposing Cα atoms of the tetrameric pore domains using all four S5 and S6 helices. From the superposition, it becomes apparent that the S1-S4 domains in TRPV4 are organized in a completely novel manner (Fig. 5d,e) . While the S1-S4 domain has a similar four-helix-bundle structure as in other TRPV channels ( Supplementary Fig. 6 ), it rotates ~90° counterclockwise around the S4 helix, as viewed from the extracellular side (Fig. 5d,e) in comparison with the S1-S4 domain in TRPV1. This domain reorientation generates a unique packing interface between the S1-S4 and the pore domains ( Fig. 5f-h ). S3 moves toward the central pore and, together with S4, creates an extensive packing interface with S5-S6 of the adjacent subunit. Remarkably, S3 intimately contacts S6 for virtually its entire length, and bulky hydrophobic side chains from S3 and S6 interdigitate like a zipper (Fig. 5f,g ). This new feature, together with the absence of an α -helical coupling element in the S4-S5 linker, raises the possibility that gating stimuli acting on S1-S4 could act through S3 directly exerting force on S6 to open the intracellular bundle-crossing gate in S6, a novel mechanism of transducing the gating signal. Consistent with this idea, previous studies have suggested that agonist 4α PDD activates TRPV4 through binding to a pocket formed by S3 and S4 (ref. 55 ). Conceptually, structural perturbation in S3 (for example, helix bending) could directly propagate to S6 and thus pull open the intracellular gate. , and TRPV6 (PDB 5IWK) (c). The S1-S4 domains and the pore domains are indicated in green and blue, respectively. d,e, Orthogonal views of TRPV4 (green and blue) and TRPV1 (gray) transmembrane domains aligned by their pore domains (all four S5 and S6 helices). Also shown in e is a schematic diagram illustrating the reorientation of the S1-S4 domain in TRPV4. f,g, Two views showing extensive packing interactions between helices S3 and S4 from one subunit and helices S5 and S6 from an adjacent subunit in TRPV4. Side chains of tightly packed residues are shown as sticks. h, A similar view to that in g for TRPV1, showing that only S4 makes considerable contacts with the pore domain from an adjacent subunit.
Structural insights into channelopathies. Human TRPV4 mutations result in a wide spectrum of autosomal dominant diseases ranging from disability to lethality, which can be divided into three distinct groups: osteoarthropathy, skeletal dysplasias and peripheral neuropathies 22 (Fig. 6a) . We mapped known pathogenic human mutations onto our Xenopus TRPV4 channel cryo-EM structure. Most of these disease mutations are conserved between the human and frog orthologs ( Supplementary Fig. 5 ). To be consistent with the literature and for ease of understanding, residues discussed hereafter are numbered according to the human TRPV4 sequence.
The osteoarthropathy mutations G270V, R271P and F273L, located at the finger 3 loop in the ARD, reduce channel activity 56 . Furthermore, the mutant channels showed impaired membrane localization, reduced activation by agonists and a lack of activation by hypotonic stress when expressed in mammalian cells 56 . Structurally, finger 3 is strategically positioned at the cytoplasmic assembly interface between subunits (Fig. 6b) . This is a shared structural feature among TRPV channels, in which finger 3 may affect channel gating by enabling cooperativity between subunits 24, 27 . In TRPV4, the side chain of F273 interacts with side chains of a network of aromatic residues both within the same subunit and from an adjacent subunit (Fig. 6b) . Our structure immediately offers a plausible explanation for how the F273L substitution might weaken intersubunit interactions, thus impairing gating transitions. G270V and R271P in finger 3 may introduce a similar destabilizing effect.
The second group of mutations causes skeletal dysplasias characterized by irregularities in bone and cartilage growth, resulting in an abnormal skeleton with a short trunk, with disease conditions ranging from mild to lethal phenotypes [57] [58] [59] [60] [61] . These mutations, which increase channel activity, occur throughout the protein sequence but concentrate in three prominent regions. One location is in the S4-S5 linker and surrounding regions that are in close contact with the highly conserved TRP helix (Fig. 6c) , which immediately follows the C-terminal end of the S6 intracellular gate. Conceptually, conformational perturbations in the S4-S5 linker, and, hence, the TRP helix, could directly influence the S6 gate. This is consistent with the observation that this region harbors many pathological mutations, including S542Y, F592L, R594H, L596P, G600W, Y602C, I604M and T740I (Fig. 6c) . The second location is in the pore domain S5-S6, and these mutations might directly alter the S6 gate conformation (Fig. 6d) . The third location includes mutations that are scattered in amino acid sequence but cluster near the cytoplasmic assembly interface between subunits, reinforcing the importance of this interface in channel gating (Fig. 6e) .
The third group of mutations results in peripheral neuropathies associated with degeneration of motor neurons and peripheral nerves [62] [63] [64] [65] . In the primary sequence, most of these mutations, except for T701I in S6, are in the cytosolic N-terminal domains interspersed with mutations that cause other diseases. Structurally, these mutations all segregate at the outer perimeter of the tetrameric channel (Fig. 6e) . This finding leads us to speculate that, in addition to altering channel activity, these mutations might affect channel interactions with other protein partners or signaling molecules, which in turn could contribute to the broad spectrum of disease phenotypes.
Discussion
Crystals of eukaryotic membrane proteins with multiple domains often diffract X-rays to limited resolution owing to their intrinsic complexity, thus preventing atomic structure determination. Single-particle cryo-EM has proven that many membrane protein structures, apparently unsolvable by X-ray crystallography, can be resolved to near-atomic resolution. By additionally measuring anomalous X-ray diffraction, even at relatively low resolution, we can access otherwise unattainable information such as conclusively determined ion-binding sites. Such combination of anomalous X-ray diffraction and single-particle cryo-EM, as illustrated in our study, may offer significant advantages for the illumination of structure and function of other ion channels and transporters. Motivated by the physiological complexity of TRPV4 channels and the wide spectrum of disease pathologies caused by TRPV4 mutations, we carried out cryo-EM and X-ray structural analyses to illuminate the molecular basis of TRPV4 function. Despite the recent structure determination of several closely related TRPV channels, our TRPV4 structure illustrates multiple unusual structural features of this unique channel.
First, the transmembrane domains are arranged in an unconventional fashion. The S1-S4 voltage-sensor-like domain engages both S3 and S4 to form extensive interactions with the pore domain S5-S6 (Fig. 5) . In particular, S3 uses almost its entire length to tightly pack against S6 (Fig. 5f,g ), an aspect that has not been previously observed in other TRP channels or related VGICs. Structures of TRPV1 determined in distinct functional states suggest that upper and lower gates along the ion permeation pathway undergo conformational changes, whereas the S1-S4 domains remain static during channel activation 24, 25 . However, in TRPV4, the distinct S1-S4 domain arrangement suggests an alternative gating mechanism in which structural perturbations in S3 directly exert force on S6 to open the intracellular gate, given the tight packing interactions between S3 and S6. It is also important to note the possibility that this unique S1-S4 arrangement originates from the truncation construct TRPV4 cryst . Certainly, understanding the functional and biophysical consequences of this unexpected arrangement needs further investigation.
Second, the ion-conduction pore of TRPV4 also possesses features that differ from other closely related TRPV channels. The selectivity filter is in such an expanded conformation that additional molecules occupy the otherwise empty space between selectivity-filter loops (Fig. 4e,f) . The identities of these molecules, which we tentatively identify as lipids, and their functional relevance are important questions to pursue further and might reveal new roles of lipids in ion channel regulation beyond our current understanding. Anomalous X-ray diffraction analyses unambiguously identify a single ionbinding site in the selectivity filter regardless of the charges carried by the bound ion. The wide selectivity filter accommodates a single hydrated ion at nearly the same location, thus providing a straightforward explanation for the nonselective nature of the pore.
The intriguingly wide spectrum of disease phenotypes and surprisingly large set of mutations associated with a single channel protein, TRPV4, underscore its complex cellular functions and essential physiological roles. Elucidating the molecular and cellular mechanisms underlying these pathogenic mutations is paramount to understanding channel function and designing effective therapies. Our atomic model represents a fundamental step in this direction and establishes a framework for better understanding the structural and functional consequences of these mutations. Indeed, we observe that different types of disease mutations predominantly concentrate and segregate into distinct regions in the 3D structure, opening the possibility for disease-specific drug targeting to these areas. Naturally, our structure provides a molecular blueprint for such drug design approaches; however, to further facilitate drug development, it would also be important to achieve atomic structures of the channel in complex with known agonists and antagonists.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41594-018-0037-5.
Protein expression and purification. The DNA encoding the X. tropicalis TRPV4 channel (Gene ID: 100496204) was codon optimized for eukaryotic expression systems, synthesized (Genewiz, Inc.) and served as the template for subcloning. DNA fragments were ligated into a modified pPICZ-B vector (Invitrogen) with a PreScission protease cleavage site and a C-terminal GFP-His 10 tag. For flux assay and electrophysiology, the corresponding gene fragments were transferred into a modified pCEH vector with a C-terminal GFP-His 8 tag. The mutant N647Q was generated by site-directed mutagenesis.
For large-scale expression, the construct including residues 133-797 with a point mutation N647Q was expressed in Pichia pastoris. Cells were disrupted by milling (Retsch MM400) and resuspended in lysis buffer containing 50 mM Tris, pH 8.0, and 500 mM NaCl. Lysate was extracted with 2% (w/v) n-dodecyl β -d-maltopyranoside (DDM, Anatrace) for 2 h with stirring at 4 °C and then centrifuged for 1 h at 30,000g. Supernatant was added to cobalt-charged resin (G-Biosciences), and suspension was mixed by inversion for 3 h. Resin was then washed with ten column volumes of buffer containing 20 mM Tris, pH 8.0, 500 mM NaCl, 10 mM imidazole, 4 mM DDM, and 0.1 mg/ml lipid-3:1:1 POPC/ POPE/POPG (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine and 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′ -rac-glycerol)) (Avanti Polar Lipids, Inc.). Protein was digested on resin with PreScission protease at 4 °C overnight to remove the C-terminal GFP-His 10 tag. Flow-through was collected, concentrated and further purified by gel filtration using a Superose 6 column (GE Healthcare) pre-equilibrated with buffer containing 20 mM Tris, pH 8.0, 150 mM NaCl, 5 mM dithiothreitol (DTT), 1 mM DDM and 0.1 mg/ml lipid. Peak fractions corresponding to the tetrameric TRPV4 channel were collected and concentrated to ~6 mg/ml for crystallization experiments. Protein samples for cryo-EM grid preparation were prepared following the same procedure except for the gel-filtration buffer, which contained 20 mM Tris, pH 8.0, 150 mM NaCl, 5 mM DTT, 0.5 mM DDM, and 0.05 mg/ml lipid.
Cryo-EM sample preparation and imaging. 3.5 µ l of purified channel concentrated to ~4 mg/ml was pipetted onto glow-discharged gold Quantifoil R1.2/1.3 grids (Quantifoil). Grids were blotted for 2 s at ~100% humidity and flash frozen in liquid ethane using an FEI Vitrobot Mark IV (FEI). Grids were then transferred to an FEI Titan Krios (FEI) electron microscope operating at an acceleration voltage of 300 kV. Images were recorded in an automated fashion on a Gatan K2 Summit (Gatan) detector in super-resolution counting mode with a super-resolution pixel size of 0.544 Å (physical pixel size of 1.088 Å) using Image processing and map calculation. Dose-fractionated super-resolution images were 2 × 2 down sampled by Fourier cropping (final pixel size of 1.088 Å) for whole-frame and patch-based motion correction and dose filtration with MotionCor2 (ref.
67
). ~2,000 particles were manually selected using RELION to generate templates for automated particle selection 68, 69 . Following automated particle selection in RELION, false positives were manually eliminated, resulting in 85,253 particles from 1,282 images. 256 × 256 pixel particle images were extracted from the motion-corrected and dose-filtered images in RELION. The parameters of the contrast transfer function were estimated by Ctffind4 (ref. 70 ). Class averages were calculated from the initial set of 85,253 particles in RELION and used for initial model generation using EMAN2 (ref. 71 ). All 85,253 particles were included for RELION 3D auto-refine to generate an improved model for RELION 3D classification. Four of the five 3D classes appeared similar and were grouped together, resulting in 72,684 particles. The 72,684 particles were polished using RELION particle polishing, keeping only frames 2-19, corresponding to an accumulated dose of 32 e -/Å 2 . Rotational and translational parameters for the polished particles were determined using two iterations of FREALIGN global search followed by 20 iterations of FREALIGN local search, resulting in a map that achieved a resolution of 3.8 Å as assessed by Fourier shell correlation (FSC) using the 0.143 cutoff criterion 72, 73 . Reference maps were lowpass filtered to 6 Å for all FREALIGN refinement iterations.
Local resolution estimates were calculated using ResMap with the two FREALIGN half-maps as the inputs 74 . The FREALIGN map was sharpened using an isotropic B factor of -150 Å 2 before model building and coordinate refinement. The final map was sharpened to best fit the molecular transform of the refined atomic model by Diffmap (grigoriefflab.janelia.org/diffmap).
Model building and coordinate refinement. The structure of the isolated human TRPV4 ankryin repeat domain (PDB 4DX2) 34 was docked into the cryo-EM density map using UCSF CHIMERA 75 and then manually rebuilt in COOT 76 to fit the density. The remainder of the protein was de novo built into the map using bulky side chains to register the sequence. For coordinate refinement in real and reciprocal space, the cryo-EM density map of one of the half-maps was extracted in a new smaller unit cell that extended 5 Å from the model in all directions.
Real space refinement using phenix.real_space_refine 77 and reciprocal space refinement using REFMAC 78 were alternated with manual model rebuilding in COOT. Geometric and secondary structure restraints were maintained throughout refinement to minimize over fitting. To monitor the effects of over fitting during refinement, the Fourier shell correlations were calculated for the half-map used during refinement and the refined model (FSC work) as well as for the half-map that was not used at any point during refinement and the refined model (FSC free). The final model contained residues 144-530, 536-635, 657-762 and 770-784.
Crystallization and X-ray data collection and analyses. Native crystals were grown at 4 °C using hanging-drop vapor diffusion by mixing 1 µ l protein with 1 µ l reservoir solution containing 50 mM MES, pH 6.0, 100 mM NaCl, 5.5% PEG4000, and 10% glycerol. Crystals appeared overnight and grew to full size within 3 d. To identify ion-binding sites, crystals were grown in the presence of CsCl or BaCl 2 or were soaked with buffer containing GdCl 3 . For Cs + -bound crystals, in the crystallization solution, 100 mM NaCl was replaced by 100 mM CsCl. To obtain Ba 2+ -bound crystals, protein was incubated with 10 mM BaCl 2 at 4 °C for 30 min before crystallization experiments. Gd 3+ -bound crystals were obtained by soaking native crystals in buffer containing 2 mM GdCl 3 , 50 mM MES, pH 6.0, 100 mM NaCl, 5.7% PEG4000, 10% glycerol, 1 mM DDM, and 0.1 mg/ml lipid for 1 h. Crystals were transferred to reservoir solution supplemented with 100 mM NaCl, 0.5% PEG 4000, 1 mM DDM, 0.1 mg/ml lipid, and 20% glycerol and were immediately frozen in liquid nitrogen.
X-ray diffraction data were measured at the Advanced Photon Source beamline 24-ID-C with the wavelength at 1.71 Å for Cs + , Ba 2+ and Gd 3+ (Table 2 ) and were processed with the HKL2000 program suite 79 . Molecular replacement was performed using PHASER 80 , and a single subunit of the cryo-EM structure was used as the search model. One round of rigid-body refinement was carried out in REFMAC 81 before calculation of the anomalous difference Fourier maps. All structural figures were prepared in PYMOL (http://www.pymol.org/) and CHIMERA 75 . Sequences of TRPV channels were aligned using Clustal Omega 82 and adjusted manually. The sequence alignment figure was prepared using ALINE 83 .
Electrophysiological recordings. CosM6 cells were transfected with 1-2 µ g of wild-type or truncated constructs using FuGENE6 (Promega) and used for patching within 1-2 d after transfection. Symmetric internal potassium (K int , 140 mM KCl, 1 mM EGTA, 1 mM K 2 EDTA, 4 mM K 2 HPO 4 , pH 7.38) or cesium (Cs int , 150 mM CsCl, 1 mM EGTA, 1 mM K 2 EDTA, 5 mM HEPES, pH 7.38) buffers were used for single-channel recordings. Upon patch excision in the insideout configuration, the bath was perfused with K int or Cs int containing GSK101 (10 nM to 5 µ M), so that the drug was applied from the cytoplasmic side of the membrane. For experiments with divalent ions (Ca 2+ and Ba
2+
), cells were patched in symmetric buffer (75 mM CaCl 2 or BaCl 2, respectively, with 5 mM HEPES, pH 7.3). Upon patch excision, the bath was perfused with K int including 10 nM of GSK101. Recordings were made and digitized with the Axopatch 1D patch-clamp amplifier and the Digidata 1200 digitizer (Molecular Devices). Data were collected at 10 kHz, low-pass filtered at 5 kHz and analyzed with the pClamp software suite (Molecular Devices). The pipettes with bubble number (BN) 84 4.5-5.0 (~2 M Ohm in symmetric K int ) were fabricated from the Kimble Chase soda lime glass with a Sutter P-86 puller (Sutter Instruments). All measurements were carried out at -30 mV membrane potential or as specified in the text. Rubidium flux assay. CosM6 cells were transfected with 1µ g of wild-type or truncated constructs per well in a 12-well dish using FuGENE6 (Promega) and were used for experiments in 24 h. Radioactive 86 Rb + flux assay was performed as described previously 85 . Briefly, the transfected cells were loaded with radioactive rubidium in DMEM media (1 µ Ci/ml 86 RbCl, PerkinElmer) for 6 h. After incubation, DMEM in the wells was replaced with buffer containing 105 mM NaCl, 6 mM CsCl, 1 mM MgCl 2 , 5 mM CaCl 2 , 10 mM Glucose, 90 mM of D-mannitol, 10 mM HEPES, pH 7.4. For measuring activation, 40 nM, 200 nM or 1 µ M GSK101 was added. For measuring blockage, 1 µ M GSK101 with 1 mM GdCl 3 or 40 nM GSK101 with 10 µ M GSK219 were added. At time points of 2.5, 5, 7.5, 15, 25 and 40 min, media in the wells were collected for radioactivity measurements and were replaced with equal volumes of fresh media with drugs. Finally, cells were lysed with 2% SDS, and lysate was collected. Radioactivity measurements were performed on a TRI-CARB 2900TR liquid scintillation analyzer (Packard Bioscience Company). Rubidium efflux was calculated as a fraction of the cumulative amount.
The normalized data from the GSK101 dose-response experiments (GSK101 at 0, 40, 200 and 1000 nM) were used to estimate the apparent steady-state GSK101 activation constants for wild-type Xenopus TRPV4 and TRPV4 cryst . The nonspecific leak at zero GSK101 was fitted with function f(t)= 1 -e -kL×t between 0 and ∞ . The derived constant kL was then applied in fitting the GSK101-induced signals using function f(t)= A × (1 -e (-kL + k1)×t ) + (1 -A)× (1 -e -kL×t ), where k1 is the activation constant and A is a parameter that accounts for a fraction of radioactive 86 Rb + that cannot be transported outside the cells through TRPV4 channels (for example, being trapped in cellular compartments or due to channel inactivation during the course of experiments). The activation constants for wild-type and TRPV4 cryst were
